LIMCH1 and cervical cancer: Two of the signature genes, HLA-DQB1 and LIMCH1, displayed independent prognostic significance when investigated in a large population-based patient cohort by IHC, indicating a promising role as prognostic biomarkers guiding cervical cancer treatment.